Synthesis and Antiproliferative Activity of Imidazole and Triazole Derivatives of Flavonoids
- Autores: Sable P.M.1, Potey L.C.2
- 
							Afiliações: 
							- University Department of Pharmaceutical Sciences
- Hi-Tech College of Pharmacy
 
- Edição: Volume 52, Nº 5 (2018)
- Páginas: 438-443
- Seção: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245236
- DOI: https://doi.org/10.1007/s11094-018-1836-z
- ID: 245236
Citar
Resumo
Flavones can play a potential role in estrogen dependent breast cancer due to greater reactivity of imidazole and triazole heterocycles which have been investigated in this work. We emphasized on synthesis of flavones derivatives with imidazole (2a, 2b, 2c) and triazole (3a, 3b, 3c) nucleus as a fundamental hetero-aromatic system with modifications, which have been confirmed by TLC, IR, NMR and mass spectrometry data. The synthesized compound were studied as non-steroidal aromatase inhibitors and evaluated for in vitro anti-breast cancer activity against MCF-7 cell line through SRB assay. The triazole derivative 3a with nitro substitution (H-bond accepting group) was found to be more active in comparison to standard drug letrozole.
Palavras-chave
Sobre autores
Prafulla Sable
University Department of Pharmaceutical Sciences
							Autor responsável pela correspondência
							Email: prafullasable@yahoo.com
				                					                																			                												                	Índia, 							Nagpur, Maharashtra						
Lata Potey
Hi-Tech College of Pharmacy
														Email: prafullasable@yahoo.com
				                					                																			                												                	Índia, 							Chandrapur, Maharashtra						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					